Biovotion
Z├╝rich
About Biovotion
Biovotion has developed an accurate, wearable sensing technology, that allows for medical-quality vital sign monitoring (VSM) in daily life. The platform combines medical-quality VSM with design, wearability, convenience, and prices of the consumer market. The system (multi-sensor platform plus sophisticated algorithms) is intergrated into cloud infrastructures to provide users with data on par with standard hospital systems and can be stepwise expanded with additional physiological parameters. Current parameters include heart rate, blood oxygenation, blood perfusion, temperature and movement/activity. The first VSM generation is also expected to include heart rate variability, respiratory rate, energy expenditure, and sleep and stress monitoring. The management team is internationally recognised for its expertise in wearable monitoring. The company holds a broad IP portfolio.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.5M
- Funding stage: M&A
- Last round: Series A (Jul 2017)
- Website: biovotion.com
- Phone: +41 4-4515-6174
Industries & Categories
Diabetes, Fitness, Health Care, Medical Device, mHealth
Social Profiles
Canonical: https://fsome.com/organization/biovotion-114328 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.